Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Nazha

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Seminars in Hematology|November 21, 2017
Impact of social media for the hematologist/oncologistNour Abuhadra, Navneet S Majhail, Aziz Nazha
JCO Clinical Cancer Informatics|December 19, 2025
Autonomous Analysis of Curated Patient Data Using a Large Language Model-Based Multiagent FrameworkJiasheng Wang, David M Swoboda, Aziz Nazha
Leukemia & Lymphoma|December 24, 2013
Paroxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosisAziz Nazha, Jeffrey L Jorgensen, Srdan Verstovsek
Archives of Disease in Childhood. Education and Practice Edition|February 9, 2021
What is machine learning?Orkun Baloglu, Samir Q Latifi, Aziz Nazha
Leukemia & Lymphoma|March 30, 2017
Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failureSagar S Patel, Mikkael A Sekeres, Aziz Nazha
Acta Medica Academica|July 3, 2019
Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?Yazan F Madanat, Matt E Kalaycio, Aziz Nazha
JCO Clinical Cancer Informatics|January 7, 2026
Tumor Board-Inspired Multiagent Artificial Intelligence System for Interpreting Oncology GuidelinesJiasheng Wang, Kirti Arora, David M Swoboda, et al.
Critical Reviews in Oncology/Hematology|July 13, 2016
Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?Aziz Nazha, Joseph D Khoury, Srdan Verstovsek, et al.
Blood Reviews|May 11, 2016
Chronic myelomoncytic leukemia: Are we finally solving the identity crisis?Aziz Nazha, Thomas Prebet, Steven Gore, et al.
Expert Opinion on Pharmacotherapy|July 24, 2013
Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemiaAziz Nazha, Hagop Kantarjian, Jorge Cortes, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Seminars in Hematology|November 21, 2017
Impact of social media for the hematologist/oncologistNour Abuhadra, Navneet S Majhail, Aziz Nazha
JCO Clinical Cancer Informatics|December 19, 2025
Autonomous Analysis of Curated Patient Data Using a Large Language Model-Based Multiagent FrameworkJiasheng Wang, David M Swoboda, Aziz Nazha
Leukemia & Lymphoma|December 24, 2013
Paroxysmal nocturnal hemoglobinuria is not a cause of anemia in patients with myelofibrosisAziz Nazha, Jeffrey L Jorgensen, Srdan Verstovsek
Archives of Disease in Childhood. Education and Practice Edition|February 9, 2021
What is machine learning?Orkun Baloglu, Samir Q Latifi, Aziz Nazha
Leukemia & Lymphoma|March 30, 2017
Prognostic models in predicting outcomes in myelodysplastic syndromes after hypomethylating agent failureSagar S Patel, Mikkael A Sekeres, Aziz Nazha
Acta Medica Academica|July 3, 2019
Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?Yazan F Madanat, Matt E Kalaycio, Aziz Nazha
JCO Clinical Cancer Informatics|January 7, 2026
Tumor Board-Inspired Multiagent Artificial Intelligence System for Interpreting Oncology GuidelinesJiasheng Wang, Kirti Arora, David M Swoboda, et al.
Critical Reviews in Oncology/Hematology|July 13, 2016
Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?Aziz Nazha, Joseph D Khoury, Srdan Verstovsek, et al.
Blood Reviews|May 11, 2016
Chronic myelomoncytic leukemia: Are we finally solving the identity crisis?Aziz Nazha, Thomas Prebet, Steven Gore, et al.
Expert Opinion on Pharmacotherapy|July 24, 2013
Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemiaAziz Nazha, Hagop Kantarjian, Jorge Cortes, et al.
Pageof 13